journal
MENU ▼
Read by QxMD icon Read
search

International Journal of Rheumatic Diseases

journal
https://www.readbyqxmd.com/read/29707909/evolving-concepts-in-classification-of-systemic-vasculitis-where-are-we-and-what-is-the-way-forward
#1
Richard A Watts
No abstract text is available yet for this article.
April 29, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29700971/can-a-disaster-affect-rheumatoid-arthritis-status-a-retrospective-cohort-study-after-the-2011-triple-disaster-in-fukushima-japan
#2
Sae Ochi, Shigeaki Kato, Claire Leppold, Tomohiro Morita, Masaharu Tsubokura, Tomoyoshi Oikawa, Ryuzaburo Shineha, Yukio Kanazawa, Masatoshi Fujiwara
OBJECTIVE: As status of rheumatoid arthritis (RA) is highly affected by environmental factors, a catastrophic disaster may also affect RA activity. Herein we conducted a retrospective cohort study in the disaster area of the 2011 triple disaster in Fukushima, Japan: an earthquake, tsunamis and a nuclear accident. METHODS: Clinical records of RA patients who attended a hospital near the Fukushima Daiichi Nuclear Power Plant were collected. For those who underwent whole-body counter testing, internal radiation exposure levels were also collected...
April 26, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29676040/can-genetic-studies-predict-treatment-response-in-antineutrophil-cytoplasmic-antibody-associated-vasculitis
#3
Masayoshi Harigai
No abstract text is available yet for this article.
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29673120/differences-in-clinical-presentation-and-incidence-of-cardiopulmonary-involvement-in-late-onset-versus-early-onset-systemic-sclerosis-inception-cohort-study
#4
Suparaporn Wangkaew, Phiriya Phiriyakrit, Vittawin Sawangduan, Narawudt Prasertwittayakij, Juntima Euathrongchit
INTRODUCTION: Data regarding the incidence rate (IR) of cardiopulmonary involvement in comparison between late-onset SSc and early-onset SSc are limited. OBJECTIVE: To compare the prevalence of clinical manifestations and the IR of cardiopulmonary involvement compared between the two subgroups. METHODS: An inception cohort of SSc patients seen at the Rheumatology Clinic, Maharaj Nakorn Chiang Mai Hospital, between January 2010 and June 2016, was used...
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29673090/maintenance-of-remission-in-antineutrophil-cytoplasm-antibody-associated-vasculitides
#5
Loïc Guillevin, Benjamin Terrier
No abstract text is available yet for this article.
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29673080/systemic-sclerosis-and-malignancy
#6
Gokhan Sargin, Taskin Senturk, Songul Cildag
BACKGROUND: Systemic sclerosis (SSc) has increased risk of morbidity and mortality due to pulmonary fibrosis, pulmonary arterial hypertension, renal crisis, infections and malignancies. Chemical exposure, smoking and cytotoxic drugs increase the malignancy risk in rheumatic diseases including SSc. We aim to evaluate characteristics, identify risk factors and mortality in SSc patients with malignancies. METHODS: One hundred and fifty-three patients with SSc (24 male, 129 female, with mean age of 56...
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29671956/atherosclerosis-and-autoimmunity-a-growing-relationship
#7
REVIEW
Maryam Sanjadi, Ziba Rezvanie Sichanie, Hamidreza Totonchi, Jafar Karami, Ramazan Rezaei, Saeed Aslani
Atherosclerosis is regarded as one of the leading causes of mortality and morbidity in the world. Nowadays, it seems that atherosclerosis cannot be defined merely through the Framingham traditional risk factors and that autoimmunity settings exert a remarkable role in its mechanobiology. Individuals with autoimmune disorders show enhanced occurrence of cardiovascular complications and subclinical atherosclerosis. The mechanisms underlying the atherosclerosis in disorders like rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome, systemic sclerosis and Sjögren's syndrome, seem to be the classical risk factors...
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29671953/bone-marrow-as-a-target-organ-of-systemic-lupus-erythematosus-analysis-of-cases-with-myelofibrosis
#8
Döndü Üsküdar Cansu, Hava Üsküdar Teke, Serap Işiksoy, Cengiz Korkmaz
AIM: Cytopenia in the course of systemic lupus erythematosus (SLE) may be due to multiple factors. In this study, we aimed primarily to evaluate the detailed results of bone marrow (BM) biopsies of SLE patients, secondly to determine the myelofibrosis (MF) frequency and thirdly to compare BM morphologic findings as well as the clinical and laboratory parameters between groups (with MF and without MF) in cytopenic SLE patients. METHODS: We retrospectively analyzed 224 SLE patients' files...
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29671942/comparative-efficacy-and-safety-of-biosimilar-infliximab-and-originator-infliximab-in-combination-with-methotrexate-in-patients-with-active-rheumatoid-arthritis-a-meta-analysis-of-randomized-controlled-trials
#9
Sang-Cheol Bae, Young Ho Lee
OBJECTIVE: We aimed to assess the relative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate (MTX) compared to placebo plus MTX in active rheumatoid arthritis (RA). METHODS: We performed a Bayesian network meta-analysis to combine direct and indirect evidence from randomized controlled trials (RCTs) examining the efficacy and safety of biosimilar + MTX and infliximab + MTX and placebo + MTX (MTX group) in patients with active RA despite treatment with MTX...
April 19, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29667341/septic-arthritis-of-the-knee-due-to-gemella-morbillorum
#10
LETTER
Marie-Charlotte Desmottes, Quentin Brehier, Ewa Bertolini, Irène Monteiro, William Terreaux
No abstract text is available yet for this article.
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29667340/erasmus-syndrome-systemic-sclerosis-and-silicosis-co-occurrence
#11
LETTER
Zühre Sarı Sürmelİ, Nurdan Oruçoğlu
No abstract text is available yet for this article.
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29667330/no-increased-risk-of-herpes-zoster-in-tnf-inhibitor-and-non-tnf-inhibitor-users-with-rheumatoid-arthritis-epidemiological-study-using-the-japanese-health-insurance-database
#12
Ryoko Sakai, Shoko Kasai, Fumio Hirano, Sayoko Harada, Mari Kihara, Waka Yokoyama, Michi Tsutsumino, Kenji Nagasaka, Ryuji Koike, Hisashi Yamanaka, Nobuyuki Miyasaka, Masayoshi Harigai
OBJECTIVE: It is controversial whether the use of biological disease-modifying antirheumatic drugs (DMARDs) increases the risk of herpes zoster (HZ). We aimed to evaluate the risks of HZ in tumor necrosis factor inhibitor (TNFI) and non-TNFI users with rheumatoid arthritis (RA) over 3 years in Japan. METHOD: Using the Japanese health insurance database, we assigned patients with at least one RA diagnostic code and one prescription for any DMARDs (RA cases) recorded between January 2005 and December 2013 to the RA group...
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29667324/estimation-of-cost-savings-between-2011-and-2014-attributed-to-infliximab-biosimilar-in-the-south-korean-healthcare-market-real-world-evidence-using-a-nationwide-database
#13
Jiyoun Kim, Dongmun Ha, Inmyung Song, Haesun Park, Sang-Won Lee, Eui-Kyung Lee, Ju-Young Shin
AIM: The introduction of biosimilars is expected to reduce the cost of biologic drugs, but the actual cost savings have not yet been quantified in Korea. The aim of this study was to estimate the annual cost savings attributed to the introduction of infliximab biosimilar. METHODS: We conducted a retrospective analysis using data from the Health Insurance Review and Assessment Service-National Patients Sample (HIRA-NPS) between 2011 and 2014. The study subjects were patients who were treated with infliximab, adalimumab or etanercept...
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29667308/diagnosis-and-management-of-giant-cell-arteritis-an-asia-pacific-perspective
#14
Jem V Ninan, Susan Lester, Catherine L Hill
No abstract text is available yet for this article.
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29665281/management-of-vascular-beh%C3%A3-et-s-disease
#15
Fatma Alibaz-Oner, Haner Direskeneli
No abstract text is available yet for this article.
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29665245/micb-002-and-micb-014-protect-against-rheumatoid-arthritis-whereas-mica-009-and-mica-a6-are-associated-with-rheumatoid-arthritis-in-a-hainan-han-chinese-population
#16
Yong Wang, Sangsang Li, Chunjing Chen, Qizhi Luo, Yu Li, Limin Liu, Xiaoling Fu, Ping Yu, Fuyan Wang
AIM: Rheumatoid arthritis (RA) as an inflammatory autoimmune disease affects the synovial joints as well as other organs and tissues. Since aberrant expression of MIC molecules has been observed in RA patient, MIC genotypes might play certain roles in the development of RA. METHOD: To explore the association of MICA and MICB polymorphisms with RA in a Han Chinese population in Hainan Island, samples from 172 RA and 137 healthy controls were genotyped for MICA and MICB...
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29664210/differential-clinical-presentation-of-adamantiades-beh%C3%A3-et-s-disease-in-non-endemic-and-endemic-areas-retrospective-data-from-a-middle-european-cohort-study
#17
Thomas Moosmann, Cécilia Veraar, Jürgen Brunner, Gustav Fraedrich, Andreas Frech, Wolfgang Horninger, Gudrun Ratzinger, Werner Streif, Barbara Teuchner, Johann Willeit, Manuela Zlamy, Tobias De Zordo, Michael Schirmer
OBJECTIVES: To assess demographical and clinical data in a Middle-European cohort of patients with Adamantiades-Behçet's disease (ABD), together with the use of medication in adherence to international guidelines. METHODS: In a retrospective cohort study, in- and outpatients of an Austrian secondary and tertiary university hospital center were analyzed independent from the medical discipline involved. After ethics approval, screening for ABD-patients in the clinical information system resulted in 1821 documents from 1997 to 2016...
April 17, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29624920/lack-of-association-between-vitamin-d-receptor-bsmi-apai-polymorphisms-and-osteoporosis-risk-a-pooled-analysis-on-chinese-individuals
#18
Qing-Xian Wang, Shi-Meng Zhao, Ya-Bin Zhou, Cheng Zhang
BACKGROUND: As for the association between vitamin D receptor (VDR) gene polymorphisms and osteoporosis, the current results have yielded conflicts. Therefore, we performed a pooled analysis based on Chinese individuals to provide comprehensive data on the association between VDR BsmI, ApaI, Tru9I polymorphisms and osteoporosis risk. METHODS: Studies were identified using PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure and Chinese Biology Medicine databases through to January 2017...
April 6, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29624883/diagnosis-and-management-of-ada2-deficient-polyarteritis-nodosa
#19
Andrea Human, Christian Pagnoux
No abstract text is available yet for this article.
April 6, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/29624881/study-on-association-of-human-leukocyte-antigen-drb1-alleles-in-rheumatoid-arthritis-within-bangladeshi-population
#20
Maksuma Begum, Humayun Sattar, Syed A Haq, Md Nazrul Islam, Sushanta K Saha, M Masudul Hassan, Ritu Saha, Md Shahriar Kabir
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic, systemic and autoimmune disease affecting 0.5-1% of the world population. Genetic and environmental factors are already established as being involved in the development of RA. Different human leukocyte antigen (HLA)-DRB1 alleles have major pathogenic effects to the development of RA. OBJECTIVE: To determine the HLA-DRB1 allelic frequency of RA in one Bangladeshi tertiary care center. METHODS: This case-control study was conducted at the Microbiology and Rheumatology Department of Bangabandhu Sheikh Mujib Medical University (BSMMU)...
April 6, 2018: International Journal of Rheumatic Diseases
journal
journal
42006
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"